<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385864</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00908-37</org_study_id>
    <nct_id>NCT02385864</nct_id>
  </id_info>
  <brief_title>CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension</brief_title>
  <acronym>POP-ART</acronym>
  <official_title>Effect of the Continuous Positive Airway Pressure on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Resistant hypertension is defined as uncontrolled blood pressure (BP ≥ 140/90mmHg) despite
      the current use of three or more antihypertensive drugs at full doses, including a diuretic.
      Obstructive Sleep Apnea (OSA) is at high risk for cardiovascular morbidity and is highly
      prevalent in patients with resistant hypertension.

      The prospective observational POP-ART study will assess the efficacy of continuous positive
      airway pressure (CPAP) treatment on BP in patients with resistant hypertension and collect
      data from usual care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive Sleep Apnea is highly prevalent in patients with resistant hypertension and
      several studies have assessed the effect of CPAP treatment on BP.

      But only few studies have raised data about the effect of CPAP treatment on BP in patients
      with resistant hypertension.

      Hypertension is moreover associated with increased arterial stiffness, but no data are
      available in patients with resistant hypertension.

      The purpose of this study is to demonstrate that OSA has a major impact in resistant
      hypertension, whose effects on BP and arterial stiffness can partially be reversible with
      CPAP treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean variation in BP at 6 months, assessed by 24h ambulatory BP monitoring</measure>
    <time_frame>6 months from baseline assessment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>OSA prevalence in patients with resistant hypertension</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BP variability assessed by home self BP measurments</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial stiffness assessed by pulse wave velocity and QKD interval</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antihypertensive treatment consumption</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP treatment observance</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">166</enrollment>
  <condition>Hypertension, Resistant to Conventional Therapy</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with resistant hypertension
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents

          -  Patient with severe OSA (apnea-hypopnea index &gt; 30 or &gt; or equal to 15 with excessive
             daytime sleepiness), or with mild to moderate OSA without excessive daytime
             sleepiness, or without OSA.

          -  Ambulatory patient

        Exclusion Criteria:

          -  Body mass index ≥40 kg/m2

          -  Other identifiable causes of hypertension

          -  Contraindication to CPAP treatment or patient already treated with CPAP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Philippe Baguet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Mutualiste, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gilles Barone-Rochette, MD, PhD</last_name>
    <phone>(+33) 4 76 76 51 72</phone>
    <email>gbarone@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Louis Pepin, MD, PhD</last_name>
    <phone>(+33) 4 76 76 92 65</phone>
    <email>jpepin@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique du Tondu</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Coste, MD</last_name>
      <phone>(+33) 5 56 99 62 67</phone>
      <email>olivier.coste@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Gosse, Md, PhD</last_name>
      <phone>(+33)5 56 79 58 89</phone>
      <email>philippe.gosse@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique des Eaux Claires, Groupe Hospitalier Mutualiste</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe Baguet, MD, PhD</last_name>
      <phone>(+33)4 76 70 70 54</phone>
      <email>jpbaguet@ghm-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Christophe Dessus</last_name>
      <phone>(+33) 4 76 70 76 98</phone>
      <email>c.dessus@ghm-grenoble.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Barone-Rochette, MD, PhD</last_name>
      <phone>(+33) 4 76 76 51 72</phone>
      <email>gbarone@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Louis Pepin, MD, PhD</last_name>
      <phone>(+33)4 76 76 92 65</phone>
      <email>jpepin@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 4, 2016</last_update_submitted>
  <last_update_submitted_qc>March 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Coronary Vasospasm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

